Literature DB >> 15715527

Role of progestins in contraception.

Risto Erkkola1, Britt-Marie Landgren.   

Abstract

Progestins have been used for contraception for more than 30 years. The main goal was to develop a contraceptive method devoid of the metabolic or clinical side-effects associated with the use of estrogens. The development of new contraceptive methods and formulations is time-consuming and requires devotion, belief, and also strong economical basis. As a result of this endeavor new methods have been developed: oral progestins, implants, injectables, intrauterine hormonal systems, and vaginal rings. Progestin-only contraceptives may be preferable in some situations, which have absolute or relative contraindications to estrogen, side-effects to estrogen containing hormonal contraception, lactation, and comfort and feasibility of formulations for long-term use. At present, emergency contraception is also performed with progestin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15715527     DOI: 10.1111/j.0001-6349.2005.00759.x

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  11 in total

Review 1.  Steroid receptor/coactivator binding inhibitors: An update.

Authors:  Kornelia J Skowron; Kenneth Booker; Changfeng Cheng; Simone Creed; Brian P David; Phillip R Lazzara; Amy Lian; Zamia Siddiqui; Thomas E Speltz; Terry W Moore
Journal:  Mol Cell Endocrinol       Date:  2019-06-01       Impact factor: 4.102

2.  Appreciation for analysis of how levonorgestrel works and reservations with the use of meloxicam as emergency contraception.

Authors:  A Patrick Schneider; Christopher Kubat; Christine M Zainer
Journal:  Linacre Q       Date:  2016-02

3.  Oral contraceptive pill use before pregnancy and respiratory outcomes in early childhood.

Authors:  Dana B Hancock; Siri E Håberg; Kari Furu; Kristina W Whitworth; Per Nafstad; Wenche Nystad; Stephanie J London
Journal:  Pediatr Allergy Immunol       Date:  2011-02-07       Impact factor: 6.377

Review 4.  Contraceptive Strategies in Women With Heart Failure or With Cardiac Transplantation.

Authors:  Anjli Maroo; Johnny Chahine
Journal:  Curr Heart Fail Rep       Date:  2018-06

5.  Antiepileptic drugs and other medications: what interactions may arise?

Authors:  Ram Mani; John R Pollard
Journal:  Curr Treat Options Neurol       Date:  2009-07       Impact factor: 3.598

6.  Contraceptive considerations for breastfeeding women within Jewish law.

Authors:  Ilana R Chertok; Deena R Zimmerman
Journal:  Int Breastfeed J       Date:  2007-01-04       Impact factor: 3.461

7.  Protective Effect of Vitamins C and E on Depot-Medroxyprogesterone Acetate-Induced Ovarian Oxidative Stress In Vivo.

Authors:  Atik Ismiyati; I Wayan Arsana Wiyasa; Dwi Yuni Nur Hidayati
Journal:  J Toxicol       Date:  2016-02-07

8.  The Effects of Weak and Strong CYP3A Induction by Rifampicin on the Pharmacokinetics of Five Progestins and Ethinylestradiol Compared to Midazolam.

Authors:  Herbert Wiesinger; Stefan Klein; Antje Rottmann; Bettina Nowotny; Kai Riecke; Isabella Gashaw; Margarete Brudny-Klöppel; Robert Fricke; Joachim Höchel; Christian Friedrich
Journal:  Clin Pharmacol Ther       Date:  2020-05-11       Impact factor: 6.875

9.  Comparison of contraceptive failures associated with CYP3A4-inducing drug-drug interactions by route of hormonal contraceptive in an adverse event reporting system.

Authors:  Tomiko Sunaga; Brian Cicali; Stephan Schmidt; Joshua Brown
Journal:  Contraception       Date:  2020-12-17       Impact factor: 3.375

10.  The breast cancer epidemic: 10 facts.

Authors:  A Patrick Schneider; Christine M Zainer; Christopher Kevin Kubat; Nancy K Mullen; Amberly K Windisch
Journal:  Linacre Q       Date:  2014-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.